The sensitivity of breast cancer cells to epirubicin (EPI) is closely related to the efficacy of the drug and the prognosis of patients. A growing body of research has suggested that autophagy is involved in the treatment of a variety of cancers, including breast cancer, and modifies the sensitivity of anticancer drugs. However, the mechanism by which autophagy participates in cancer therapy and modulates drug sensitivity has not been fully elucidated. In this study, we showed that the expression of Autophagy/Beclin 1 regulator 1 (Ambra1), a key protein of autophagy, was negatively correlated with EPI sensitivity in breast cancer cells. In addition, it altered the sensitivity of breast cancer cells to EPI by regulating EPI- LV-ATG12, Lentiviral vector-ATG12; p62, SQSTM1/p62.
including breast cancer. [7] [8] [9] Nevertheless, the mechanisms by which autophagy participates in cancer treatment and modulates drug sensitivity have not been established. Autophagy/Beclin 1 regulator 1 (Ambra1) is a protein essential for autophagy induction. [10] [11] [12] Meanwhile, it is also important for the execution of apoptosis. [13] [14] [15] The levels of Ambra1 in cells are critical for determining the rate of apoptosis. 16 Therefore, the level of Ambra1 may modify the sensitivity of breast cancer cells to EPI. So far, few studies have reported on the role of Ambra1 in breast cancer; in particular, there is a lack of evidence that Ambra1 is involved in the sensitivity of breast cancer cells to chemotherapy. Autophagy-related protein 12 (ATG12) is an ubiquitin-like protein that conjugates to ATG5 to form an ATG12-ATG5 conjugate. The conjugate promotes the lipidation of ATG8
(LC3) and directs its correct subcellular localization, which is necessary for the elongation of phagophores and the maturation of autophagosomes. [17] [18] [19] [20] Thus, ATG12 is an important protein in regulating autophagy. However, it is unclear whether there is an interaction between Ambra1 and ATG12.
In this study, MDA-MB-231, SK-Br-3 and MCF-7 breast cancer cells were used as the cell model. It was found that the level of Ambra1 altered the sensitivity of breast cancer cells to EPI by regulating the occurrence of EPI-induced autophagy. In addition, ATG12
was a downstream protein of Ambra1 in regulating EPI-induced autophagy. Consequently, Ambra1 is an important factor in modulating the sensitivity of breast cancer cells to EPI.
| MATERIALS AND METHODS

| Cell culture
MCF-7, MDA-MB-231 and SK-Br-3 cells were from the cell bank of the Chinese Academy of Sciences (Shanghai, China). MCF-7 and SKBr-3 cells were cultured in MEM media (Thermo Fisher, Waltham, MA, USA), and MDA-MB-231 cells were cultured in L15 media (Thermo Fisher), supplemented with 10% FBS (Thermo Fisher), 100 units/mL penicillin and 100 μg/mL streptomycin at 37°C in a humidified incubator with 5% CO 2 . Before the study, the cells were passaged for 6 generations. The identity of the cell lines was determined by short tandem repeat profiling.
| Agents and antibodies
Epirubicin was from Pfizer Pharmaceuticals (Dalian, China). Bafilomycin A1 (BAF1) was from Sigma-Aldrich (Shanghai) Trading (Shanghai, China). The annexin V-PE/7-AAD Apoptosis Assay Kit was from Nanjing KeyGen Biotech (Nanjing, China). The caspase-9 activity assay kit, the lactate dehydrogenase (LDH) cytotoxicity assay kit, and the Cell Counting Kit-8 (CCK-8) were from the Beyotime Institute of Biotechnology (Shanghai, China). Anti-MAPLC3β (H50) and anti-Ambra1 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Anti-GAPDH antibody was from MultiSciences (Lianke) Biotech (Shanghai, China). Anti-p62, ATG12, and ATG5 were from Abcam (HongKong, China). Anti-Beclin 1 was from CST (Danvers, MA, USA). 
| Cell viability and death assay
| Apoptosis assay
For the apoptosis assay, cells were seeded at 5 × 10 5 cells in 12.5 cm 2 tissue culture flasks and were treated as described for the CCK-8 assay for the indicated times. Afterward, cells were trypsinized at the indicated time and dyed with annexin V-PE and 7-AAD according to the manufacturer's instructions. Then, the apoptosis was detected with a flow cytometer.
| Caspase-9 activity assay
Cells were collected after treatment with the assay agents for the indicated time, and 30 μL of lysis buffer was added to the collected cells. The cells were resuspended in the lysis buffer and incubated on ice with light agitation for 30 minutes. Lysates were centrifuged at 1500 g for 5 minutes; 10 μL of supernatant was used to assay the protein concentration with Bradford reagent, and another 10 μL was used to assay caspase-9 activity. The activity of caspase-9 was assayed with Ac-LEHD-pNA as a substrate; the samples were incubated at 37°C for 2 hours, and the OD values were detected at 405 nm with a microplate reader. 
| Western blotting
| Autophagy assay
Microtubule-associated protein 1 light chain 3 (LC3) puncta was monitored by RFP-GFP-LC3 tandem fluorescent probe (Genechem).
Autophagosomes have both RFP and GFP signals, whereas autolysosomes emit only an RFP signal because GFP is quenched in the acidic lysosomal environment. 22 The protein levels of LC3
(LC3-I/LC3-II) and SQSTM1/p62 (p62) were detected by western blotting.
| Real-time quantitative PCR
RNA was extracted by using Trizol Reagent (Generay Biotech 
| Mice xenograft models
To generate murine subcutaneous tumors, 1 × All animal experiments conformed to the provisions of the Declaration of Helsinki (as revised in Fortaleza, Brazil, October 2013) and were approved by the Ethics Committee of the Second Affiliated
Hospital of Guangxi Medical University.
| Statistical analyses
Statistical comparisons of the mean values were performed using ANOVA. P < 0.05 was considered statistically significant.
| RESULTS
| Knockdown of Ambra1 increases the sensitivity of breast cancer cells to epirubicin
First, the expression of Ambra1 was examined by western blotting in MCF-7, MDA-MB-231 and SK-Br-3 breast cancer cells ( Figure 1A ). 
| Overexpression of Ambra1 increases the resistance of breast cancer cells to epirubicin
To further characterize the role of Ambra1 in EPI-induced cell death, a lentiviral vector-AMBRA1 transfected with full-length human AMBRA1 cDNA and an empty vector (EVam, as a control) were constructed to overexpress Ambra1 in MCF-7, MDA-MB-231 and SKBr-3 cells. After transfection with LV-AMBRA1 for 48 hours, the expression of Ambra1 was significantly increased in both mRNA and protein ( Figure 2A ,B, *P < 0.05). In addition, the overexpression of Ambra1 led to a significant increase in cell viability as well as decreases in cell death, caspase-9 activity and apoptosis after EPI treatment ( Figure 2C ,D, *P < 0.05). Thus, overexpression of Ambra1 increases EPI-resistance by inhibiting apoptosis in breast cancer cells.
LC3 is currently the most widely used autophagosome marker. After treatment, the fluorescence of RFP and GFP was observed with a fluorescence microscope (600×) and LC3 puncta were counted. The nucleus was stained with Hoechst. The results (mean ± SE) are from 3 independent experiments (*P < 0.05, **P > 0.05). In parallel, the proteins of Ambra1, LC3-I/II and p62 were detected by western blotting (H). Then, (I) and (J), cell viability, cell death, caspase-9 activity and apoptosis were analyzed. The results (mean ± SE) are from 3 independent experiments (*P < 0.05, **P > 0.05)
To explore whether autophagy mediated the effects of Ambra1-mediated resistance to the apoptotic response after treatment with EPI, we knocked down Beclin 1 by sh-BECLIN 1 in MDA-MB-231 cells and corresponding cells that highly expressed Ambra1 (Figure 2F) . Beclin 1 is a critical autophagic regulator in mammalian cells. 23 The 
| Ambra1 regulates epirubicin-induced autophagy in breast cancer cells
As a key factor in autophagy, we explored whether Ambra1 was also involved in EPI-induced autophagy in breast cancer cells. To Figure 4D ,E, **P > 0.05); moreover, the re-expression of ATG12 did not disturb the increased sensitivity of cells to EPI induced by Ambra1 knockdown (Figure 4F ,G, **P > 0.05). The autophagy was detected by LC3-I conversion into LC3-II, p62 degradation and LC3 puncta. Therefore, ATG12 is a downstream protein of the Ambra1-mediated autophagy pathway and is an important protein for Ambra1 to modulate EPI sensitivity.
| Knockdown of Ambra1 enhances epirubicin sensitivity in vivo
To confirm whether downregulation of Ambra1 also increased the Ambra1 is a key protein in the crosstalk between autophagy and apoptosis. Its expression may determine the fate of cells. [13] [14] [15] [16] Studies on several cell lines have shown that high expression of Ambra1 is beneficial for cell survival. 10, 14, 16, 28 In this study, we . The results (mean ± SE) are from 3 independent experiments (*P < 0.05, **P > 0.05). C, After knocking down of Ambra1, MDA-MB-231 cells we inoculated BALB/c nude mice. Then, the mice were treated with 5 mg/ kg EPI for indicated time, and the volume and weight of the tumor were measured (*P < 0.05) F I G U R E 4 ATG12 was a downstream protein of Ambra1 in epirubicin (EPI)-induced autophagy. A, MDA-MB-231 cells were incubated with scrambled shRNA or sh-BECLIN 1 or 2450 for 48 h. The protein of Ambra1, ATG12, ATG12-ATG5 and ATG5 was detected by western blotting. At the same time, the mRNA of ATG12 and ATG5 were examined by quantitative RT-PCR (qRT-PCR). The results (mean ± SE) are from 3 independent experiments (*P < 0.05, **P > 0.05). B, MDA-MB-231 cells were transfected with LV-ATG12 or empty vector (EVat) for 48 h. The proteins and mRNA of ATG12 and Ambra1 were detected by western blotting and qRT-PCR, respectively. The results (mean ± SE) are from 3 independent experiments (*P < 0.05, **P > 0.05). C, MDA-MB-231 cells expressing RFP-GFP-LC3 were incubated with LV-ATG12 or empty vector (EVat) for 48 h. After that, the cells were treated with EPI for another 24 h in the presence or absence of Bafilomycin A1 (BAF1, 20 nmol/L); then, autophagy was assessed with the LC3 puncta. The results (mean ± SE) are from 3 independent experiments (*P < 0.05). D, MDA-MB-231 cells were transfected with scramble shRNA or 2450 for 48 h, and then incubated with LV-ATG12 or empty vector (EVat) for another 48 h. Subsequently, the cells were treated with EPI for 24 h. After treatment, the proteins of ATG12, LC3-I/II and p62 were detected by western blotting (D). In parallel, autophagy was assessed with LC3 puncta in MDA-MB-231 cells that expressed RFP-GFP-LC3 (E). The results (mean ± SE) are from 3 independent experiments (*P < 0.05, **P > 0.05). Moreover, (F) and (G), cell viability, cell death, caspase-9 activity and apoptosis were measured, respectively. The results (mean ± SE) are from 3 independent experiments (*P < 0.05, **P > 0.05)
In summary, Ambra1 is an important protein that determines whether EPI-treated breast cancer cells undergo apoptosis or autophagy. Its level modulates the sensitivity of breast cancer cells to EPI.
In addition, ATG12 is a downstream protein of Ambra1 during EPIinduced autophagy and plays an important role in regulating EPI sensitivity.
We conclude that Ambra1 regulates EPI-induced autophagy in breast cancer cells by targeting ATG12, thereby modulating EPI sensitivity. This finding also indicates that Ambra1 might be a potential target for breast cancer treatment.
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